Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Green technology to boost production of malaria ‘wonder drug’

12.02.2007
New technologies that make the large-scale extraction of a natural antimalarial ‘wonder drug’ both cheaper and greener are to be developed and trialled in a new European effort.

Since it was first extracted from the herb Sweet Wormwood (Artemisia annua) by Chinese scientists in the 1980s, artemisinin has proven to be a potent anti-malarial treatment.

Most patients treated with Artemisinin-based Combination Treatments (ACTs) show clinical improvement within 24 hours.

However, large-scale production of artemisinin drugs, which are used as part of a combination therapy to avoid development of resistance by malaria parasites, has so far relied on extraction technology based on the petroleum derived hexane - a toxic and potentially explosive substance.

... more about:
»Artemisia »Artemisinin »Malaria »annua »hexane »solvent

In a search for a better extraction system, a team of chemical engineers from the University of Bath (UK) and a specialist UK business, FSC Development Services Ltd, were commissioned (in 2005) by the non-profit Medicines for Malaria Venture (MMV) and the Dutch Government to evaluate a range of new technologies that could replace hexane extraction, and make large-scale production both cheaper and more environmentally friendly.

In research published in the Journal of Natural Products, Dr Alexei Lapkin from the University’s Department of Chemical Engineering highlights three extraction processes that can compete with hexane extraction economically, as well as being better for the environment.

Now, using a £500,000 grant from the Dutch Government through MMV, some of these technologies will be demonstrated and tested over the next 12 months by a consortium of European companies and universities.

“Increased production of Artemisia annua is now happening in many countries around the world, but if we are to reduce the costs of the final drugs we need to increase yield through higher yielding varieties and introduce new, more efficient, safer and more environmentally friendly extraction systems,” said Dr Lapkin.

“The intention for this project is to build a small-scale demonstrator unit in Bath and prove its viability by extracting artemisinin from Artemisia annua plants grown in different countries and regions.

“The project will also explore purification methods of raw extracts to obtain material of good enough quality for pharmaceutical companies to buy for further processing into drug treatments.

“Our focus is on driving down the cost of extraction to help make this ‘wonder drug’ more readily available to the people who need it.”

Artemisinin is extracted from the Artemisia annua plant using a solvent which helps separate the different parts of the plant. The raw artemisinin is then purified to produce the final drug.

The most common solvent used in the current extraction process is hexane, an alkane hydrocarbon produced from crude oil that is both toxic and explosive, making it damaging to the environment and expensive to handle safely.

The research team examined alternative extraction technologies using either supercritical carbon dioxide (scCO2), hydrofluorocarbon HFC-134a, ionic liquids (ILs) or ethanol as alternative solvents. In this initial study they used data provided by technology developers in the UK, and compared it with the known data for hexane extraction.

They found that the technologies using scCO2, HFC and ILs, all of which are non-flammable solvents, gave faster extraction times and a more complete extraction of the useful substances in the leaf.

These solvents are also considerably safer, with no risk of explosions, and were much greener, having a lower environmental impact in use, and offering the potential for biodegradability after use.

Ionic liquid and HFC-134a technologies in particular showed considerable promise, and the analysis suggests that they could compete with hexane extraction in terms of cost-effectiveness.

Over the next nine months, a demonstrator unit using HFC-134a will be built at the University of Bath in collaboration with Ineos Fluor (UK). Bioniqs Ltd, a spin-off company from University of York (UK), will continue their work on ionic liquids extraction, and University of Bremen (Germany) will be testing extraction with another widely used solvent, ethanol.

The whole project is being co-ordinated by FSC Development Services Ltd, which is based in Gloucestershire (UK).

“MMV is pleased to support this project even though it is not our traditional line of work, as the focus is purely on technology rather than developing new drugs or treatments,” said Dr Ian Bathurst, Director of Drug Discovery & Technology at MMV.

“Developing technology that makes the extraction process as efficient and cost-effective as possible makes the mass production of artemisinin economically, environmentally and socially viable. This will have a significant impact on the new ACTs we are developing.”

Malcom Cutler, head of FSC Development Services Ltd., said: “This project is not about profit for companies; tackling malaria is not a business, but a challenge we must do everything we can to overcome.”

As the plasmodium parasite which causes malaria is able to mutate and develop resistance to the drugs used against it, it is important to have a variety of treatments available and to continue developing new medicines.

Andrew McLaughlin | alfa
Further information:
http://www.bath.ac.uk/news/2007/2/12/artemisia.html

Further reports about: Artemisia Artemisinin Malaria annua hexane solvent

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>